Ultrasound prediction of Zika virus-associated congenital injury using the profile of fetal growth. by Walker, Christie L et al.
RESEARCH ARTICLE
Ultrasound prediction of Zika virus-associated
congenital injury using the profile of fetal
growth
Christie L. Walker1, Noah Ehinger2, Brittney Mason2, Elizabeth Oler1, Marie-Te´rèse
E. Little3, Eric O. Ohuma4,5, Aris T. Papageorghiou6, Unzila Nayeri7*, Christine Curry2*,
Kristina M. Adams WaldorfID8,9,10*
1 Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, University of Washington,
Seattle, Washington, United States of America, 2 Department of Obstetrics & Gynecology, University of
Miami Health System, Miami, Florida, United States of America, 3 4th Dimension Biomedical Research
Communications, Victoria, British Columbia, Canada, 4 Nuffield Department of Medicine, Centre for Tropical
Medicine and Global Health, University of Oxford, Oxford, United Kingdom, 5 Nuffield Department of
Orthopaedics, Rheumatology & Musculoskeletal Sciences, Centre for Statistics in Medicine, University of
Oxford, Oxford, United Kingdom, 6 Nuffield Department of Obstetrics & Gynaecology and Oxford Maternal &
Perinatal Health Institute, Green Templeton College, University of Oxford, Oxford, United Kingdom,
7 Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, University of Miami Health
System, Miami, Florida, United States of America, 8 Department of Obstetrics & Gynecology, University of
Washington, Seattle, Washington, United States of America, 9 Department of Global Health, University of
Washington, Seattle, Washington, United States of America, 10 Sahlgrenska Academy, University of
Gothenburg, Gothenburg University, Gothenburg, Sweden
* adamsk@uw.edu (KMAW); clcurry@gmail.com (CC); unzilanayeri@gmail.com (UN)
Abstract
Zika virus (ZIKV) is a mosquito-transmitted flavivirus, recently linked to microcephaly and
central nervous system anomalies following infection in pregnancy. Striking findings of dis-
proportionate growth with a smaller than expected head relative to body length have been
observed more commonly among fetuses with exposure to ZIKV in utero compared to preg-
nancies without ZIKV infection regardless of other signs of congenital infection including
microcephaly. This study’s objective was to determine the diagnostic accuracy of femur-
sparing profile of intrauterine growth restriction for the identification of ZIKV-associated con-
genital injuries on postnatal testing. A retrospective cohort study of pregnant women with
possible or confirmed ZIKV infection between January 1, 2016 and December 31, 2017
were included. Subjects were excluded if no prenatal ultrasound was available. A femur-
sparing profile of growth restriction determined using INTERGROWTH-21st sonographic
standard for head circumference to femur length (HC: FL). Congenital injuries were deter-
mined postnatally by imaging, comprehensive eye exam and standard newborn hearing
screen. A total of 111 pregnant women diagnosed with ZIKV infection underwent fetal ultra-
sound and 95 neonates had complete postnatal evaluation. Prenatal microcephaly was
detected in 5% of fetuses (6/111). Postnatal testing detected ZIKV-associated congenital
injuries in 25% of neonates (24/95). A HC: FL Z-score� -1.3 had a 52% specificity (95% CI
41–63%), 82% negative predictive value (NPV, 95% CI 73–88%) for the detection of ZIKV-
associated congenital injuries in the neonatal period. A more stringent threshold with a Z-
score� -2 was associated with a 90% specificity (95% CI 81–95%), 81% NPV (95% CI 77–
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85%). Excluding cases of fetal microcephaly, HC: FL (Z-score� -2) demonstrated a similar
specificity (89%, 95% CI 81–95%) with superior NPV (87%, 95% CI 84–90%). The sono-
graphic recognition of a normally proportioned fetus may be useful prenatally to exclude a
wider spectrum of ZIKV-associated congenital injuries detected postnatally.
Introduction
A recent epidemic of Zika virus (ZIKV), a mosquito-transmitted flavivirus, has been linked to
microcephaly and other fetal central nervous system anomalies following infection in preg-
nancy. [1, 2] Microcephaly or structural brain anomalies are diagnosed prenatally in only
4–9% of pregnancies with a ZIKV infection, but approximately 30% of infants are diagnosed
with a wider spectrum of anomalies postnatally after eye examination, auditory testing and
additional brain imaging. [3–7] Similar to other teratogenic viruses, infection in the first tri-
mester is associated with the highest risk of microcephaly and the other structural and devel-
opmental anomalies. [8–10] Prenatal recognition of the congenital Zika syndrome has been
limited to obvious structural anomalies such as calcifications, ventriculomegaly or microceph-
aly detectable by ultrasound. [2, 11–13] This strategy fails to identify all infants who are diag-
nosed with ZIKV-associated injury postnatally through vision and hearing tests and additional
brain imaging. [7, 14] Although ultrasound remains the most available method for prenatal
diagnosis of ZIKV-associated birth defects, studies suggest it is insufficient to predict the wid-
ening array of congenital ZIKV injury. [15–18] The lack of a prenatal diagnostic test to either
predict or rule out ZIKV-associated anomalies represents a major clinical challenge in ZIKV-
endemic areas.
Intrauterine growth restriction (IUGR) is a known sequela of ZIKV and other teratogenic
viral infections [19], but whether aberrant fetal growth might predict congenital injuries in
pregnancies exposed to ZIKV is unknown. We first observed an unusual femur-sparing pat-
tern of IUGR in a nonhuman primate model of congenital ZIKV infection; in these experi-
ments, there was an arrest of fetal head growth, while the long bones (e.g. femur) continued to
grow normally. [20, 21] This striking profile of fetal growth was also seen in a majority of preg-
nant women from New York City acquiring ZIKV through travel; a lack of postnatal data pre-
cluded correlation with congenital ZIKV injury in this study. [22] Investigators reporting
outcomes of Brazilian infants with congenital Zika syndrome have noted a similar discrepancy
between fetal or neonatal length and head circumference (HC), which has been referred to as
“disproportionate microcephaly”. [12, 23] Notably, this “femur-sparing” profile of IUGR con-
trasts with the pattern of growth restriction due to placental insufficiency (“brain-sparing
IUGR”) and other viral infections (e.g. symmetric IUGR for cytomegalovirus), but is consis-
tent with the known ZIKV tropism for fetal neural progenitor cells.
In this study, prenatal ultrasound biometric measurements of the fetus from pregnancies
with a ZIKV infection were correlated with postnatal testing to determine the diagnostic accu-
racy of a femur-sparing profile of IUGR to predict ZIKV-associated congenital injury. We
hypothesized that sonographic detection of an abnormally proportioned fetal body, defined by
a small HC relative to femur length (FL), would identify a larger proportion of fetuses diag-
nosed postnatally with ZIKV-associated injuries. The prenatal diagnosis of aberrant fetal
growth may aid in identification of neonates at high risk for impaired development who war-
rant early interventions.
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Material and methods
Study design and institutional review board approval
Pregnant women were screened for possible ZIKV exposure between January 1, 2016 and
December 31, 2017 at a tertiary care center in Miami, Florida. Following a positive result on
screening questionnaire, women were tested according to the U.S. Centers for Disease Control
and Prevention (CDC) guidelines. All pregnant women testing positive for confirmed or prob-
able ZIKV infection between 2016 through 2017 were included in the study and stratified by
gestational age at presumed exposure. When possible, the timing of exposure was based on
known travel dates with gestational age determined by American College of Obstetricians and
Gynecologists guidelines. Typically, prenatal ultrasound imaging was performed every 3–4
weeks per CDC recommendations.
The University of Miami investigators obtained Institutional Review Board approval (Jack-
son Health System, #201660689) as a retrospective chart review and informed consent was not
required. Subjects were excluded if they did not meet CDC criteria for a “possible ZIKV infec-
tion” or did not have an ultrasound scan during pregnancy. Charts were abstracted and de-
identified data was sent to the University of Washington for analysis of the following data vari-
ables: exposure trimester, gestational age at each ultrasound, fetal biometric measures from
each ultrasound [HC, abdominal circumference (AC), FL, estimated fetal weight, ventricle and
cerebellar measurements], birth defects, gestational age at intake and delivery, results of any
abnormal ultrasound imaging from fetal or neonatal ultrasound, magnetic resonance imaging
(MRI) or audiology tests, and Zika virus symptoms and laboratory testing results from mother
and neonates, birthweight, and pregnancy outcome (termination of pregnancy, preterm birth,
stillbirth, term birth). The University of Washington Institutional Review Board deemed that
analysis of these variables did not engage in human subjects activity. Note that a prior publica-
tion reports the pregnancy outcomes from 88 of the 111 subjects in this study [24]; there is no
scientific overlap as this study did not analyze the diagnostic accuracy of prenatal ultrasound
to predict pregnancy outcomes.
Diagnosis of Zika virus infection
Pregnant women were diagnosed with ZIKV infection according to the most current CDC
guidelines at the time of testing. Women were included if laboratory testing supported a con-
firmed or possible ZIKV infection by either detection of: 1) ZIKV viral ribonucleic acid (RNA)
in a maternal, placental or fetal specimen, 2) a positive/equivocal ZIKV IgM and ZIKV plaque
reduction neutralization test (PRNT) titer� 10, regardless of dengue virus PRNT value; or, 3)
a negative ZIKV IgM, and positive/equivocal dengue virus IgM, and ZIKV PRNT titer� 10,
regardless of dengue virus PRNT value. [25] Newborns were tested according to CDC guide-
lines for possible congenital ZIKV infection. [26] A neonatal ZIKV infection was diagnosed by
positive polymerase chain reaction (PCR) for ZIKV from serum, urine or cerebrospinal fluid.
Ultrasound methodology
Choice of sonographic standard is critical for determining normal and aberrant fetal growth
and, ideally, is validated within specific populations. Pregnant women in the continental U.S.
are ethnically diverse and while U.S. ethnic-specific growth charts for fetal biometric measures
exist, standards for fetal body ratios have not been published. [27] Therefore, we applied the
International Fetal and Newborn Growth Consortium for the 21st Century (INTER-
GROWTH-21st) standards, which was a multi-ethnic study of more than 13,000 pregnancies
in 18 countries with which we could calculate HC: FL ratio Z-scores. [28, 29]
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Biparietal diameter (BPD) is a fetal biometric measure used to estimate fetal weight and
growth. Consistent with many centers in the United States using the Hadlock sonographic
standard [30], the BPD was measured from outer to inner skull diameter; however, the
INTERGROWTH-21st standard requires BPD to be measured from outer to outer skull diam-
eter. Due to these differences, we used HC rather than BPD measurements in this study.
Definitions for IUGR and microcephaly vary and different standards have been applied to
congenital ZIKV infection. We reviewed the available definitions and chose typical standards
of an AC Z-score� -1�3 (10th percentile) for IUGR and a fetal HC Z-score� -2 (~2�3 percen-
tile) for microcephaly. [31, 32] Estimated fetal weight is often used to define IUGR; however,
INTERGROWTH-21st fetal weight Z-scores could not be calculated due to differences in BPD
measurements, as described above.
Fetal body ratios comparing HC or AC to FL were calculated using a Z-score� -1�3 as a
diagnostic threshold for abnormal growth trajectory, which has previously been shown to
identify higher rates of growth restriction than use of a single fetal biometry. [22]
Postnatal evaluation
Following delivery all neonates were evaluated by pediatricians for evidence of ZIKV-associ-
ated postnatal sequelae with initial ultrasound head imaging followed by MRI if abnormalities
were seen or suspected. Serum and urine ZIKV testing was performed as detailed above. The
pediatrician determined postnatal testing, which most often included a cranial ultrasound,
auditory screening (automated auditory brainstem response) and serum testing (Fig 1). Addi-
tional studies including eye examination, MRI and cerebrospinal fluid (CSF) testing were com-
pleted due to provider discretion and findings of prior testing.
Primary and secondary outcomes
The primary outcome was the diagnostic accuracy of a fetal body ratio (HC: FL), measured
using prenatal ultrasound, to identify neonates with ZIKV-associated anomalies and abnormal
postnatal testing. We evaluated two diagnostic thresholds for the HC: FL fetal body ratio: 1)
the 10th centile (Z-score� -1 �3) and, 2) the 3rd centile (Z-score� -2). A secondary outcome
was the diagnostic accuracy of the HC: FL to detect ZIKV-associated anomalies and abnormal
postnatal testing in normocephalic fetuses (HC > -2).
Statistical analysis
Biometric measures from each ultrasound were recorded in millimeters (mm) with standard-
ized Z-scores calculated based on gestational age at time of ultrasound. The performance of
each measure to identify postnatal ZIKV infection was evaluated. Sensitivity, specificity, posi-
tive and negative predictive values (PPV and NPV, respectively), and positive and negative
likelihood ratios (LR) were calculated. A true positive case had confirmed anomalies on post-
natal evaluation that could be attributed to congenital ZIKV infection based on clinical exam,
imaging, auditory and visual testing. Other fetal abnormalities not attributed to ZIKV infec-
tion are shown in S1 Table. True negatives were infants with no postnatal findings of congeni-
tal ZIKV infection. R studio (open source) software was used to perform statistical analysis.
Results
Patient characteristics
A total of 111 pregnant women were diagnosed with ZIKV infection and were included in this
analysis (Fig 1). Acquisition of ZIKV occurred from local mosquito-borne transmission in
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Florida, sexual exposure or travel to endemic areas. The majority of women were asymptom-
atic (95/111) at the time of diagnosis and tested as part of a universal screening policy. Sixteen
women were symptomatic, most commonly with a rash (14/16, 88%), fever (9/16, 56%), myal-
gia (5/16, 31%) and conjunctivitis (4/16, 25%) (Table 1, S2 Table). Using CDC diagnostic crite-
ria, 6% of the women had an acute ZIKV infection (7/111, positive serum ZIKV PCR), 13%
had ZIKV infection with unknown timing of infection and 81% had a probable ZIKV infection
(90/111; S2 Table).
Pregnancy and neonatal outcomes
Of the 111 pregnancies, 16 women delivered at outside institutions; therefore, no birth out-
comes were available. Of the 95 pregnancies with birth outcomes available, 14% (13/95)
resulted in a preterm delivery ranging from 28 to 36 weeks with the remainder delivering at
term with a mean gestational age of 39.7 ± 1.1 weeks (Table 1, S2 Table). Among preterm neo-
nates, the mean birth weight was 2284.6 ± 661.8 grams (Z-score -0.2, adjusted for gestational
age at delivery) with mean head circumference of 31.3 cm (SD 1.6, range 22–35 cm, Z-score
-0�4). Term neonates delivered at an average gestational age of 39.1 weeks with mean
Fig 1. STROBE diagram to illustrate included and excluded subjects with distribution of postnatal testing in the
neonates. Not all patients obtained the complete panel of recommended neonatal tests, which was a function of patient
choice, cost of testing, pediatrician recommendation and limited knowledge of the spectrum of congenital injuries
early in the study. Note that all neonates undergoing eye examination also had either a cranial ultrasound or auditory
examination. Seven subjects also underwent MRI imaging of the fetal head. A single neonate only had postnatal serum
ZIKV PCR and IgM, but did not have any imaging, auditory or vision testing.
https://doi.org/10.1371/journal.pone.0233023.g001
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birthweight of 3221.9 ± 410.7 grams (Z-score -0.1) and head circumference of 33�9 cm (SD
1.5cm, range 22–37 cm, Z-score -0.05).
Following delivery, 83 infants underwent cranial ultrasound, of which 7 had additional test-
ing with MRI to define abnormalities noted on initial ultrasound imaging (Table 2). Among
these 83 infants, 24 had abnormal imaging (29%) including intraventricular hemorrhage, cau-
dothalamic groove cysts, lenticulostriate vasculopathy, intracranial calcifications, ventriculo-
megaly, extra-axial fluid collections and microcephaly, and one case of severe microcephaly
with collapsed skull vault. No abnormal ultrasound findings were noted in infants that were
born preterm.
Prenatal microcephaly and fetal growth abnormalities
The mean gestational age at first prenatal ultrasound evaluation was 27.0 (±7�6) weeks. Over
the course of pregnancy, each subject underwent an ultrasound approximately every 4 weeks
after their initial visit, ranging from 14 to 40 weeks with an average of 2�4 (SD 1�4) ultrasounds
per subject. Prenatal microcephaly, defined as an HC Z-score� -2 (N = 6/111; Fig 2), was
diagnosed in 5�4% of fetuses. IUGR was identified in 9% (10/111) of pregnancies based on AC
Table 1. Pregnancy, delivery and neonatal outcomes of pregnant women diagnosed with ZIKV infection.
Prenatal Demographics All Subjects
(N = 111)
Missing Postnatal Data
(N = 17)
Normal Postnatal Findings§
(N = 73)
Any Abnormal Postnatal Finding§
(N = 24)
P value
Exposure trimester
Preconception 2 0 (0) 1 (1) 0 (0) NS
First 13 1 (6) 8 (11) 4 (17) NS
Second 13 2 (12) 7 (10) 4 (17) NS
Third 5 1 (6) 4 (5) 0 (0) NS
Unknown 78 9 (53) 53 (73) 16 (67) NS
Zika Symptoms†
Fever 9 0 (0) 4 (5) 5 (21) 0.02�
Rash 15 0 (0) 10 (14) 5 (21) NS
Myalgias 5 0 (0) 2 (3) 3 (13) NS
Conjunctivitis 4 1 (6) 1 (1) 2 (8) NS
Asymptomatic 95 15 (88) 62 (85) 18 (75) NS
Gestational age at intake
(weeks)
29.8 23.6 (7�9) 27.5 (7�7) 27.0 (6�2) NS
Gestational age at delivery
(weeks)
37.4 Unknown 38.3 (2�2) 39.0 (1�2) NS
Birthweight (grams) 2810 Unknown 3052 (580) 3243 (452) NS
Neonatal HC at birth (inches) 33.3 Unknown 33.4 (2�0) 34.0 (2.1) NS
Neonatal HC Z-score at birth 0.7 (1.2) Unknown 0.2 (1�0) 0.04 (1.7) NS
Numbers shown are mean (standard deviation) or number (%).
HC, head circumference
P Values shown compare groups with normal and abnormal postnatal testing.
�P value <0.05. NS, not significant.
†Symptoms of possible ZIKV infection by subject recall to the obstetrical provider. Some subjects had more than one symptom, therefore percentages do not add up to
100.
§Postnatal findings considered to represent abnormalities possibly associated with ZIKV infection included findings consistent with congenital ZIKV infection as
defined by the U.S. Centers for Disease Control and Prevention. [26]
https://doi.org/10.1371/journal.pone.0233023.t001
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Z-score�-1�3 (�10th centile; S3 Table). In contrast, 51% (56/111) of fetuses had a small HC:
FL body ratio and 29% (N = 32/111) had an abnormal AC: FL body ratio at some time in preg-
nancy (Z-score� -1�3, Table 3).
Diagnostic accuracy of HC: FL for prediction of abnormal postnatal testing
Of the 95 neonates with postnatal testing, 25% (24/95) had abnormal postnatal testing associ-
ated with congenital ZIKV infection (Table 2). Congenital ZIKV injuries were most likely to
be detected by either cranial ultrasound (20/83, 24%) or MRI (3/7, 43%); as not all postnatal
tests were performed in all subjects, this result may be subject to selection bias. In contrast, an
abnormal neonatal eye exam or auditory test occurred in 5/34 (15%) and 2/82 (2%), respec-
tively. Overall, the sensitivity and PPV of either the fetal HC or HC: FL was poor for detection
of abnormal postnatal testing associated with ZIKV congenital injury (Table 4). The best pre-
natal indicator for congenital ZIKV-associated injury was the diagnosis of microcephaly, but
this occurred in only 5% (6/111) of fetuses in our cohort [HC Z-score� -2; specificity 97%,
95% CI 90–99; NPV 80%, 95% CI 77–82; positive LR 3�6, 95% CI 0�8–16�6]. In contrast, an
HC: FL ratio less than the 10th (Z-score� -1�3) or the 3rd centile (Z-score� -2) occurred in at
least one ultrasound scan in 51% and 21% of fetuses, respectively. The distribution of the HC:
FL ratio by trimester of ZIKV exposure for each subject with abnormal postnatal testing is
shown in Fig 3.
Next, we asked whether disproportionate growth of the fetal head with respect to the femur,
using the HC: FL ratio, might represent a useful prenatal diagnostic test to exclude ZIKV-asso-
ciated congenital injuries diagnosed postnatally. When a threshold at the 10th centile for the
HC: FL ratio was applied, there was a 52% specificity (95% CI 41–63%), 82% NPV (95% CI
Table 2. Prenatal and postnatal diagnosis of congenital injuries associated with ZIKV infection.
Type of Anomaly N (%)
Prenatal Diagnosis 14 (13)
Prenatal Microcephaly (HC Z-score� -2) 6 (5)
IUGR (AC Z-score� -1.3) 10 (9)
Agenesis of the corpus callosum 1 (1)
Ventriculomegaly 1 (1)
Postnatal Diagnosis 24 (25)
Postnatal Microcephaly (HC at birth Z-score� -2) 5 (5)
Small for gestational age (birthweight Z-score <-1.3) 12 (13)
Ventriculomegaly 1 (1)
Caudothalmic groove cysts/vasculopathy 16 (17)
Agenesis of the corpus callosum 1 (1)
Retinal imaging abnormalities 5 (5)
Calcifications 3 (3)
Polymicrogyria 3 (3)
The numbers shown reflect either the N (%) of congenital ZIKV-associated injuries out of either 111 fetuses
undergoing ultrasound for prenatal diagnosis or 95 neonates evaluated by postnatal testing. Note that we show
individual fetal anomalies in aggregate, rather than by individual cases, to prevent possible identification of
individual neonates in this cohort with an unusual combination of anomalies. Therefore, the number of anomalies in
the prenatal and postnatal categories do not add up to the total number of fetuses (N = 14) or neonates (N = 24)
identified with anomalies.
https://doi.org/10.1371/journal.pone.0233023.t002
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Fig 2. Head circumference and head circumference: Femur length ratio by trimester of ZIKV exposure. Z-scores for fetal head
circumference (HC) and the HC to femur length (HC: FL) body ratio. The distribution of HC: FL is negatively skewed compared to
HC measurements, indicating disproportionate growth with a smaller fetal head relative to the femur length. Each color represents
data from a single ultrasound for an individual subject with colors kept consistent for each individual over time. The horizontal
dotted line indicates a Z-score of -1.3, which corresponds to the 10th centile. To simplify presentation of the data, data was shown
separated by the best estimate for trimester of ZIKV exposure (A: unknown trimester, B: first trimester, C: second trimester, D: third
trimester). Only the latest ultrasound per trimester for each subject was shown to allow discrimination between data points.
https://doi.org/10.1371/journal.pone.0233023.g002
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73–88%) and negative LR 0.8 (0.5–1.3) for postnatal abnormalities. Application of a more
stringent threshold for HC: FL at the 3rd centile (Z-score� -2) resulted in a 90% specificity
(95% CI 81–95%), 81% NPV (95% CI 77–85%) and negative LR 1.2 (0.8–1.8), improving the
ability to detect and rule out ZIKV-associated injury. We performed a final analysis to apply
the test to normocephalic fetuses, where there is the most clinical uncertainty as to whether a
congenital ZIKV-associated birth injury has occurred. In normocephalic fetuses, an HC: FL
ratio at or below the 3rd centile (Z-score� -2) demonstrated similar specificity (89%, 95% CI
81–95%) with a superior NPV (87%, 95% CI 84–90%). Overall, the HC: FL ratio performed
best for its NPV to exclude ZIKV-associated congenital injuries in the normocephalic fetus.
Discussion
Principal findings
The principal study finding is that an HC: FL ratio greater than the 3rd centile in a normoce-
phalic fetus is associated with an 87% NPV for the postnatal detection of congenital ZIKV-
associated injuries. Although the diagnosis of microcephaly (HC Z-score� -2) had a high
specificity (97%) and NPV (80%), only 25% of neonates with congenital injury were diagnosed
Table 3. Mean fetal biometric measures and body ratio Z-scores by gestational age strata.
Gestational Age Strata HC AC FL HC: FL AC: FL P values
FL vs. HC FL vs. AC
All (N = 111) 0.2 (1.4) 0.5 (1�1) 0.9 (1.1) -0.8 (1.2) -0.4 (1.1) <0.001� <0.001�
>34 weeks (N = 81) 0.0 (1.7) 0.4 (1.2) 0.8 (1.4) -0.8 (1.3) -0.4 (1.2) <0.001� <0.001�
28–33 6/7 weeks (N = 70) 0.2 (1.0) 0.5 (1.2) 0.8 (1.8) -0.6 (2.3) -0.3 (1.6) <0.001� <0.001�
24–27 6/7 weeks (N = 37) 0.2 (1.2) 0.5 (0.9) 0.9 (1.0) -0.7 (0.8) -0.4 (0.8) <0.001� <0.001�
18–23 6/7 weeks (N = 39) 0.1 (1.0) 0.6 (1.0) 0.9 (1.0) -0.7 (0.8) -0.4 (0.7) <0.001� 0.07
Mean Z-scores (standard deviation) are presented using the last ultrasound from each gestational age strata and estimated by INTERGROWTH-21st standards. [28]
�P<0.05
HC, head circumference; AC, abdominal circumference; FL, femur length; HC: FL, head circumference to femur length ratio; AC: FL, abdominal circumference to
femur length ratio.
https://doi.org/10.1371/journal.pone.0233023.t003
Table 4. Diagnostic test performance of prenatal ultrasound for the detection of ZIKV-associated anomalies.
Sensitivity Specificity PPV NPV LR+ LR-
All Subjects (N = 95)
HC Z-score� -2 13 (3–32) 97 (90–99) 50 (18–82) 80 (77–82) 3.6 (0.8–16.6) 0.9 (0.8–1.1)
HC: FL Z-score� -1.3 58 (37–78) 52 (41–63) 25 (18–33) 82 (73–88) 1.2 (0.8–1.8) 0.8 (0.5–1.3)
HC: FL Z-score� -2 25 (10–47) 90 (81–95) 40 (21–63) 81 (77–85) 2.4 (1.0–6.1) 0.8 (0.7–1.1)
Fetuses with a Normal Head Size (N = 89)
HC: FL Z-scores� -1.3 57 (34–78) 52 (41–63) 23(16–32) 83 (74–89) 1�2 (0.8–1.9) 0.8 (0.5–1.4)
HC: FL Z-scores� -2 20 (4–48) 89 (81–95) 23 (9–49) 87 (84–90) 1.8 (0.6–5.8) 0.9 (0.7–1.2)
Numbers shown reflect percent sensitivity, specificity, positive and negative predictive values, as indicated. Cases with aberrant growth were diagnosed by prenatal
ultrasound measurement of fetal biometry with application of the INTERGROWTH-21st sonographic standard to determine Z-scores for either head circumference
(HC), abdominal circumference (AC) or head circumference to femur length (HC: FL), as shown above. Data is shown for all neonates with known postnatal outcomes
(N = 95) and then, specifically for normocephalic fetuses (N = 89). Microcephaly was defined as an HC Z-score� -2.
PPV, positive predictive value (true positive/(true positives + false positives); NPV, negative predictive value (true negatives/(true negatives + false negatives); LR+,
likelihood ratio for positive test results (sensitivity/1-specificity); LR-, likelihood ratio for negative test results (1-sensitivity)/specificity; accuracy (true positives + true
negatives)/all subjects
https://doi.org/10.1371/journal.pone.0233023.t004
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Fig 3. Head circumference: Femur length ratio by trimester of ZIKV exposure among neonates with abnormal
postnatal testing.
https://doi.org/10.1371/journal.pone.0233023.g003
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with microcephaly antenatally. The remaining 75% of neonates with abnormal postnatal test-
ing were normocephalic in utero. This is consistent with prior studies showing higher rates of
postnatal abnormalities than cases of prenatal microcephaly. [7, 14] Overall, the value of the
HC: FL ratio as a prenatal diagnostic test is in its ability to provide reassurance of a healthy
neonate to pregnant women with ZIKV infection in the setting of a normocephalic, non-
anomalous fetus.
Notably, the sensitivity and PPV of the HC: FL ratio was poor, which is in accordance with
other studies of the limited sensitivity of ultrasound to detect the broader spectrum of congeni-
tal ZIKV-associated injuries. [7, 14, 16] Unfortunately, the addition of fetal MRI to prenatal
ultrasound does not appear to increase sensitivity for detection of congenital ZIKV-associated
injuries. [9] A study to determine the diagnostic accuracy of a diverse set of sonographic
abnormalities (e.g. placentomegaly, oligohydramnios) in combination with known ZIKV-
associated anomalies found an adjusted odds ratio of 27.2 (95% CI 2�5–296�6) for abnormal
neonatal outcomes. [16] The real-world application of various sonographic findings for the
prediction of ZIKV-associated postnatal outcomes becomes challenging, particularly when
there is a single abnormal finding that might be atypical of ZIKV-associated anomalies (e.g.
oligohydramnios). The same study also found that fetal Doppler measurements of the middle
cerebral artery were associated with abnormal neonatal outcomes (adjusted odds ratio of 20�2,
95% CI 3�2–132�6) [16]; these measurements can be technically difficult to obtain by sonogra-
phers with limited training in low- and middle-income countries. In contrast, obtaining the
HC: FL ratio only requires that the sonographer measure the HC and FL, which represents
skills typically learned early in ultrasound training. The simplicity of the HC: FL ratio makes it
widely accessible to sonographers and obstetrical providers in high- and low-resource settings.
Clinical and research implications
Ultrasound remains the most useful and easily available prenatal tool to evaluate fetuses
exposed to ZIKV in utero. This study identifies a novel tool that may aid obstetricians, radiolo-
gists and pediatricians to more accurately predict fetuses and newborns with a lower risk for
the greater spectrum of ZIKV-associated congenital injury. The concept of a femur-sparing
profile of fetal growth restriction is quite new, but may represent a valuable indicator of fetal
injury for other neuroinvasive, teratogenic viruses. Prospective trials are necessary to validate
this tool and determine appropriate reference ranges, which may be population-specific. The
long-term follow up of children affected by the congenital Zika syndrome, particularly those
with a less severe phenotype, is essential to understand the range of congenital ZIKV injuries
and their implications for thorough and adequate prenatal counseling.
Strengths and limitations
The main study strength was the application of a novel prenatal diagnostic test for congenital
injury ZIKV-associated injury that can be readily applied to low- and middle-income coun-
tries where ZIKV has become endemic. A second strength is the availability of prenatal ultra-
sound and postnatal imaging and testing data for nearly all participants. Study limitations
include the retrospective nature of the study at a single center in the U.S and lack of a matched
control group. However, INTERGROWTH-21st standards were used to estimate Z-scores,
which were derived from more than 13,000 pregnancies. Information regarding the spectrum
of congenital ZIKV-associated injuries accumulated over the course of our study; therefore,
not all neonates underwent complete postnatal testing early in the study, but 89% had at least a
cranial ultrasound. Incomplete postnatal testing may have contributed to underestimation of
the number of cases with congenital injury, which would bias our results towards the null
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hypothesis. We did not have access to maternal age or ethnicity for the participants as this was
not obtained in our secondary analysis, but an earlier study containing nearly 80% of the same
subjects reported maternal age and a multi-ethnic cohort. [24] Ideally, ethnic and population-
specific fetal growth standards for fetal body ratios would be applied to our data [27]; however,
fetal body ratio nomograms are available from the INTERGROWTH-21st sonographic stan-
dard, which was a multi-ethnic study of fetal growth (18 countries) and has been previously
used to evaluate ZIKV-associated congenital microcephaly in Brazil. [33] We acknowledge
that diagnosis of ZIKV is complicated by cross-reactivity with dengue virus and other flavivi-
ruses. In some of the cases in this study, a ZIKV diagnosis was made by laboratory testing posi-
tive for an “unspecified flavivirus”, which is a current testing limitation and is also inherent to
other ZIKV pregnancy cohorts. Finally, although we focused the hypothesis on detection of a
femur-sparing (disproportionate) profile of growth restriction, we recognize that fetuses with
a symmetric (proportionate) growth restriction are also likely at risk for congenital ZIKV
injury.
Conclusions
Congenital ZIKV infection can significantly alter fetal neurodevelopment and result in lifelong
neurologic morbidity including seizures, blindness, hearing loss, developmental delay, and
motor impairment. [4, 12, 14] Prenatal diagnosis is currently limited to the recognition of
structural brain anomalies by ultrasound or, in some cases, fetal MRI. In pregnancies that lack
sonographic anomalies, we have no reliable test to detect postnatal sequelae. We identify the
first prenatal diagnostic strategy to predict approximately 9 out of 10 fetuses that are at very
low risk for the early postnatal detection of congenital injuries. A disproportionately small
fetal head with respect to the femur may reflect a partial loss of neuroprogenitor cells and a
more subtle phenotype of ZIKV-associated injury. Although the HC: FL ratio may offer some
reassurance, the knowledge of long-term outcomes and developmental problems in children
exposed to ZIKV in utero remains immature. Further research to link child outcomes with
sonographic data obtained during pregnancy will be important for learning how we can prena-
tally diagnose the spectrum of less obvious injuries associated with congenital ZIKV infection.
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